0001628280-24-001690.txt : 20240118 0001628280-24-001690.hdr.sgml : 20240118 20240118163815 ACCESSION NUMBER: 0001628280-24-001690 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240116 FILED AS OF DATE: 20240118 DATE AS OF CHANGE: 20240118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christensen Jamie CENTRAL INDEX KEY: 0001599324 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 24542327 MAIL ADDRESS: STREET 1: C/O MIRATI THERAPEUTICS, INC. STREET 2: 9393 TOWNE CENTRE DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3545 CRAY COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 3545 CRAY COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wk-form4_1705613883.xml FORM 4 X0508 4 2024-01-16 0 0001576263 Mirati Therapeutics, Inc. MRTX 0001599324 Christensen Jamie C/O MIRATI THERAPEUTICS, INC. 3545 CRAY COURT SAN DIEGO CA 92121 0 1 0 0 EVP & Chief Scientific Officer 0 Common Stock 2024-01-16 4 S 0 966 59.02 D 156558 D Common Stock 2024-01-16 4 S 0 631 59.02 D 155927 D Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022. Includes 347 shares acquired under the ESPP Purchase on 05/31/2023 and 42 shares acquired under the ESPP purchase on 11/30/2023. Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 15, 2021. /s/ John Moriarty, Attorney-in-Fact 2024-01-18